Crohn's Disease Treatment Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Incidence of Crohn’s Disease Due to Lifestyle Changes
- Increasing Awareness About Crohn’s Disease, and the Availability of Treatments
Challenges
- High Cost of Treatment
- Delay In Diagnosis and Lack of Awareness
Crohn's Disease Treatment Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.2% |
|
Base Year Market Size (2024) |
USD 14.05 billion |
|
Forecast Year Market Size (2037) |
USD 23.99 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of crohn's disease treatment is estimated at USD 14.55 billion.
Crohn's Disease Treatment Market size was over USD 14.05 billion in 2024 and is anticipated to cross USD 23.99 billion by 2037, growing at more than 4.2% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is anticipated to account for largest revenue share by 2037, owing to increasing awareness about Crohn’s disease, and need to develop innovative inflammatory bowel disease treatment solutions in the region.
The major players in the market are Pfizer Inc., Allergan, AbbVie Inc., Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Ferring B.V., Eli Lilly Company, Hoffman-La Roche, Bristol-Myers Squibb, among others.
